Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

27.31
BATS BZX Real-Time Price
As of 12:41pm ET
 +0.56 / +2.09%
Today’s Change
8.31
Today|||52-Week Range
27.63
+83.17%
Year-to-Date
Vertex (VRTX) Triple Combination CF Studies Data Positive
Jul 19 / Zacks.com - Paid Partner Content
Why Are Shares of Exelixis (EXEL) Up 77% So Far in 2017?
Jul 13 / Zacks.com - Paid Partner Content
Valeant (VRX) To Sell Obagi for $190 Million to Lower Debt
Jul 19 / Zacks.com - Paid Partner Content
BioDelivery-Purdue Pharma Ink Marketing Deal for Pain Drug
Jul 13 / Zacks.com - Paid Partner Content
Agenus (AGEN) Catches Eye: Stock Moves Up 8.7% in Session
Jul 19 / Zacks.com - Paid Partner Content
Exelixis Has an Enviable Chart Pattern
Jul 13 / TheStreet.com - Paid Partner Content
Arena Announces Secondary Stock Worth $150M (revised)
Jul 17 / Zacks.com - Paid Partner Content
Endocyte (ECYT) to Focus on Promising CAR-T Cell Platform
Jul 13 / Zacks.com - Paid Partner Content
Emergent BioSolutions to Buy Sanofi's Smallpox Vaccine Unit
Jul 17 / Zacks.com - Paid Partner Content
Why Exelixis (EXEL) Could Be an Impressive Growth Stock
Jul 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close26.75
Today’s open26.89
Day’s range26.88 - 27.33
Volume236,153
Average volume (3 months)3,955,259
Market cap$7.8B
Dividend yield--
Data as of 12:41pm ET, 07/20/2017

Growth & Valuation

Earnings growth (last year)+65.43%
Earnings growth (this year)+164.06%
Earnings growth (next 5 years)+46.00%
Revenue growth (last year)+415.05%
P/E ratio909.7
Price/Sales19.51
Price/Book86.83

Competitors

 Today’s
change
Today’s
% change
ICLRICON PLC-0.31-0.31%
CRLCharles River Labora...+0.81+0.81%
PRAHPRA Health Sciences ...+0.64+0.85%
PRXLPAREXEL Internationa...+0.05+0.06%
Data as of 12:39pm ET, 07/20/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.04
Annual revenue (last year)$191.5M
Annual profit (last year)-$70.2M
Net profit margin-36.68%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Executive VP, Chief Financial &
Accounting Officer
Christopher J. Senner
Corporate headquarters
South San Francisco, California

Forecasts